Disc Medicine prices an enlarged $450 million equity offering
Disc Medicine ($IRON) priced an upsized public offering of six million common shares at $75 each, generating expected gross proceeds of $450 million before underwriting discounts and expenses. Underwriters have a 30-day option to buy another 900,000 shares, which could add $67.5 million if fully exercised. Closing is expected on October 22, subject to customary conditions; the pricing announcement is not confirmation that funding has already settled. The company plans to use the money for resear
0